Prof. Dr.Necdet Özçay
Prof. Dr. Necdet Özçay
Prof. Dr.Necdet ÖzçayGeneral Surgery · Gastroenterological SurgeryVM Medical Park Ankara (Keçiören)

Prof. Dr. Necdet Özçay

Search the site

Search results

Enter at least two characters to search.

Try a search

Breast surgery

Breast cancer surgery

The extent and timing of breast cancer surgery depend on the cancer's stage, biology and your priorities. Breast and lymph-node procedures are planned alongside other cancer treatments.

Planning breast cancer care with teaching models and records

There is no single standard operation

Surgery aims to control disease locally and provide information for subsequent treatment. Options range from breast conservation to mastectomy, with lymph-node surgery considered separately. Tumour biology and spread matter as well as size. A breast cancer diagnosis does not automatically mean that an operation should be the first treatment.

Why diagnostic detail matters

The biopsy establishes tumour type, grade and treatment-related markers, including hormone receptors and HER2. Imaging evaluates the breast and axilla; additional staging tests are selected according to clinical need. Reviewing the original reports and, when necessary, pathology material helps ensure that the proposed treatment addresses the actual diagnosis.

Surgery first or systemic treatment first?

Some early cancers are treated with surgery first. Others benefit from systemic treatment before surgery to reduce disease or assess response. This changes the sequence rather than necessarily removing the need for an operation. In metastatic disease, surgery may have a different, symptom-focused role. Multidisciplinary assessment guides these distinctions.

Breast and axillary options

Breast conservation requires consideration of margins, appearance and radiotherapy. Mastectomy decisions include options for reconstruction or flat closure. Axillary needle biopsy, sentinel-node biopsy and dissection serve different purposes, and selected low-risk patients may need less intervention. The reason for each proposed procedure should be explained before consent.

What surgery and pathology establish

The surgical specimen provides information about tumour size, margins and any sampled nodes. After preoperative treatment, remaining disease is also assessed. These findings may refine the earlier stage or change the next treatment recommendation. Ask which pathology findings influence the plan rather than assuming that the operation completes all treatment.

Risks and shared decisions

Risks include bleeding, infection, fluid collection, persistent discomfort and altered sensation. Body image and emotional effects deserve attention alongside technical outcomes. Lymph-node surgery and reconstruction add distinct risks. More extensive surgery is not automatically the better choice; preferences, genetic risk and the broader treatment plan must be considered together.

Preparing for admission and discharge

Preoperative assessment addresses existing illnesses, anaesthesia, medicines and nutrition. Do not independently stop regular treatment. Discharge planning should cover wound or drain care, pain management, movement and contact details. Physiotherapy, psychological support and dietetic input may be helpful, and practical support at home should be arranged in advance.

Follow-up and warning signs

Follow-up includes pathology, additional treatment, arm function, pain and quality of life. Report new breast or chest-wall changes. Fever, expanding swelling, marked redness or unexpected drain changes need prompt advice. Sudden breathlessness or chest pain requires emergency assessment. A written plan helps coordinate care across the different specialties involved.

This information is general. The cause of symptoms, appropriate investigations and treatment options are determined through individual assessment.

Medical references